Publication: 273

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304
      QxMD      Google Scholar   
Citation:
J Thorac Oncol vol 6 (11) 1902-1906
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
1
Parents:
686  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA77597, CA11789, CA77406, CA47577, CA29165, CA41287, U10 CA031946, U10 CA033601, CA59518, CA60138, CA45389, CA37447, CA45808, CA12046, CA35421, CA16450, CA77440, CA08025, CA21060, CA47559, CA47642, CA45418, CA31983, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
               
Networks:
 
Study
CALGB-150304
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-30203
Phases:
N/A, 2
Keywords:
Lung cancer, VEGF, Eicosanoid, Celecoxib